KATHRYN DONOVAN: Open Payments
NPI 1700575099 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 21 payments from 11 companies in 2025. Trend: 2023 $1,523 · 2024 $844 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $121 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Boston Scientific Corporation | 3 | $66 |
| AtriCure, Inc. | 2 | $63 |
| Actelion Pharmaceuticals US, Inc. | 1 | $35 |
| CVRx, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Smith+Nephew, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: ENROUTE Transcarotid Neuroprotection System, ELIQUIS, SYNERGY ABLATION SYSTEM, HAWKONE, PLASMABLADE(TM), CAMZYOS, OPSUMIT, Barostim Neo System.
Industry payments across TX — which companies pay providers there.
